Saturday 17 October 2026 Export SGHT’s income statement to Excel — free account

Sight Sciences, Inc.

Sight Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.4 million, down 3.13% from fiscal 2024. In the quarter to June 2026, revenue grew 19.6%, EPS grew 65.2%, free cash flow grew 26.7% and total debt rose 2.40%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

8.28 0.52 −5.91%

Follow SGHT

Alert me

Market cap: $484.8M
P/E: 0.0×
Fwd P/E: −7.0×
Dividend yield: —
F-score: 5/9
Altman Z: 0.83
Beneish M: −3.04
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.18

Total sells 2.87

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	1	—	—	—	—	—	1	—	—	—	—
Sell	3	1	10	—	—	6	1	—	6	—	—	5

Insider Ownership 34.61%

Capital & Financial Ratios $m

Market Cap 484.78

Revenue 83.38

Net Income (29.76)

Free Cash Flow (23.33)

Net Debt (38.98)

Current Ratio 4.95

Debt/Equity 0.77

P/E ratio 0.00

Fwd P/E (6.97)

P/S ratio 5.41

P/B ratio 8.53

Past 5Y EPS Growth —

This Y EPS Growth 46.81%

Next Y EPS Growth 22.59%

Next Y revenue growth 16.75%

Next 5Y EPS Growth 10.53%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 62.23%

10-year low 10-year high

P/B against its own 10 years 97.71%

10-year low 10-year high

EV/Sales against its own 10 years 79.75%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	138	120	92	80
Receivables	14	11	10	11
Inventory	8	6	8	6
Other	—	—	—	—
	163	140	113	101

	2023	2024	2025	Q'26
Payables	2	2	1	2
ST’ Debt	2	—	—	10
Other	—	—	—	—
	12	15	11	20

Compound Annual Growth %

	10y	5y	3y
Sales	—	22.86%	2.74%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	(26.35%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	20	23	—	—	—
’25	18	20	20	20	77
’24	19	21	20	19	80
’23	19	23	20	19	81
’22	15	17	19	21	71
’21	9	13	13	15	49
’20	6	4	9	9	28

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	(6)	—	—	—
’25	(12)	(8)	(9)	(2)	(30)
’24	(10)	(9)	0	(3)	(22)
’23	(17)	(13)	(10)	(6)	(47)
’22	(22)	(18)	(20)	(16)	(76)
’21	(13)	(12)	(17)	(11)	(53)
’20	(10)	(15)	(9)	(9)	(32)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(7)	(6)	—	—	—
’25	(12)	(8)	(9)	(2)	(30)
’24	(10)	(10)	0	(4)	(23)
’23	(18)	(14)	(10)	(7)	(48)
’22	(22)	(19)	(20)	(16)	(77)
’21	(13)	(13)	(17)	(11)	(53)
’20	(10)	(16)	(9)	(9)	(33)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.24)	(0.08)	—	—	—
’25	(0.28)	(0.23)	(0.16)	(0.08)	(0.74)
’24	(0.33)	(0.25)	(0.22)	(0.23)	(1.03)
’23	(0.35)	(0.30)	(0.27)	(0.22)	(1.14)
’22	(0.49)	(0.50)	(0.46)	(0.35)	(1.80)
’21	(1.29)	(1.83)	(0.43)	(0.34)	(2.36)
’20	(0.20)	(0.88)	(0.85)	—	(3.71)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	17.00	5.35	1.04	3.30	2.03	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	42.57	18.40	15.30	8.45	9.24
People
People	Employees	—	—	—	—	184	212	250	214	216	186
	Revenue/emp, $m	—	—	0.00	0.00	0.15	0.23	0.29	0.38	0.37	0.42
Income, $m
Income, $m	Revenue	—	—	8	23	28	49	71	81	80	77
	Gross margin, %	—	—	68.95	71.97	66.68	82.41	82.67	85.34	85.50	86.17
	EBT	—	—	(14)	(26)	(35)	(63)	(86)	(55)	(51)	(38)
	EBT margin, %	—	—	(189.85)	(110.76)	(125.30)	(128.22)	(120.84)	(68.39)	(64.20)	(49.66)
	Net income	—	0	(14)	(26)	(35)	(63)	(86)	(56)	(52)	(38)
	Depreciation	—	—	0	0	1	1	1	1	1	1
Per share, $
Per share, $	Revenue	—	—	0.16	0.50	2.95	1.83	1.49	1.67	1.59	1.48
	Earnings	—	—	(0.31)	(0.55)	(3.71)	(2.36)	(1.80)	(1.14)	(1.03)	(0.74)
	Cash flow	—	—	(0.31)	(0.53)	(3.44)	(1.97)	(1.59)	(0.97)	(0.45)	(0.57)
	Capex	—	—	0.00	0.00	(0.10)	(0.03)	(0.02)	(0.02)	(0.01)	0.00
	Free cash flow	—	—	(0.31)	(0.53)	(3.54)	(2.00)	(1.61)	(0.99)	(0.45)	(0.57)
	Book value	—	—	(0.62)	(1.17)	(9.50)	8.68	3.35	2.47	1.75	1.23
	Shares, m	—	—	47	47	9	27	48	49	50	52
Valuation, ×
Valuation, ×	P/E	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	8.29	8.29	8.29	9.59	8.26	3.06	2.28	5.35
	P/B	—	—	0.00	0.00	0.00	2.02	3.68	2.06	2.09	6.47
	EV/Sales	—	—	8.21	8.21	8.21	4.95	6.15	1.77	1.30	4.71
	EV/FCF	—	—	(7.37)	(7.37)	(7.37)	(4.54)	(5.70)	(3.00)	(4.56)	(12.11)
Cash, $m
Cash, $m	Operating cash flow	—	—	(14)	(25)	(32)	(53)	(76)	(47)	(22)	(30)
	Capex	—	—	(1)	(1)	(1)	(1)	(1)	(1)	0	0
	Free cash flow	—	—	(14)	(25)	(33)	(53)	(77)	(48)	(23)	(30)
Balance, $m
Balance, $m	Working capital	—	—	4	21	61	264	192	151	124	102
	Total debt	—	—	34	78	32	33	34	34	39	40
	Net debt	—	—	30	57	(29)	(228)	(151)	(104)	(81)	(52)
	Shareholders’ equity	—	—	(29)	(55)	(89)	232	160	120	88	64
Returns, %
Returns, %	ROA	—	—	(353.10)	(133.23)	(67.01)	(35.67)	(34.97)	(29.26)	(33.29)	(29.77)
	ROIC	—	—	0.00	0.00	0.00	(701.56)	(556.90)	(223.54)	(484.25)	(188.86)
	ROE	—	—	34.17	61.85	48.34	(87.90)	(43.98)	(39.64)	(49.59)	(50.74)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
TCMD Tactile Systems Technology, Inc.	$527.6M	20.5×	22.7×	+8.61% (above 0%: growing)	+142.86% (above 0%: growing)	−86.53% (below 0%: shrinking)	76.25%	7.97%	Compare
SSII SS Innovations International, Inc.	$517.2M	— (loss-making)	— (loss-making)	+39.39% (above 0%: growing)	n/m	−16.62% (below 0%: shrinking)	50.94%	(16.29%)	Compare
DCTH Delcath Systems, Inc.	$513.9M	1,408×	— (loss-making)	+20.60% (above 0%: growing)	−12.50% (below 0%: shrinking)	−24.45% (below 0%: shrinking)	89.75%	8.22%	Compare
MASS 908 Devices Inc.	$491.5M	— (loss-making)	— (loss-making)	+23.31% (above 0%: growing)	n/m	+150.95% (above 0%: growing)	51.90%	(79.69%)	Compare
SGHT Sight Sciences, Inc.	$484.8M	— (loss-making)	— (loss-making)	+19.55% (above 0%: growing)	n/m	+26.71% (above 0%: growing)	91.39%	(16.62%)
BWAY Brainsway Ltd. Sponsored ADR	$475.8M	24.8×	— (loss-making)	+35.43% (above 0%: growing)	+40.00% (above 0%: growing)	−51.68% (below 0%: shrinking)	74.62%	13.98%	Compare
CERS Cerus Corporation	$455.5M	— (loss-making)	— (loss-making)	+5.28% (above 0%: growing)	n/m	−20.90% (below 0%: shrinking)	55.91%	(2.94%)	Compare
NPCE NeuroPace, Inc.	$438.7M	— (loss-making)	— (loss-making)	+17.05% (above 0%: growing)	n/m	−78.70% (below 0%: shrinking)	82.83%	(22.53%)	Compare
SENS Senseonics Holdings, Inc.	$435.2M	— (loss-making)	— (loss-making)	+117.82% (above 0%: growing)	n/m	−223.24% (below 0%: shrinking)	59.10%	(248.48%)	Compare
Median of peers	$483.6M	24.8×	—	+21.96%	+40.00%	−38.07%	66.86%	(9.61%)

All 149 Medical Devices stocks →

Sight Sciences, Inc. (SGHT) key facts

Concern: Sight Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $77.4 million, down 3.13% from fiscal 2024.
Concern: Sight Sciences, Inc. reported a net loss of $38.4 million, or a loss of $0.74 per share, for fiscal 2025.
Sight Sciences, Inc. (SGHT) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, SGHT traded at $8.28, a market capitalization of $484.8 million.
Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 5.4× sales.
Return on equity was −50.7% and debt-to-equity 0.77.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 0.83 (distress zone) for fiscal 2025.